Filing Details
- Accession Number:
- 0001213900-15-006828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-08 20:32:38
- Reporting Period:
- 2015-08-31
- Filing Date:
- 2015-09-08
- Accepted Time:
- 2015-09-08 20:32:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1402479 | Myos Corp | MYOS | Pharmaceutical Preparations (2834) | 208758875 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1398815 | J Robert Hariri | C/O Myos Corporation 45 Horsehill Road, Suite 106 Cedar Knolls NJ 07927 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-31 | 5,000 | $1.63 | 53,664 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-09-01 | 2,250 | $1.73 | 55,914 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-09-03 | 5,500 | $1.72 | 61,414 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-09-04 | 7,500 | $1.75 | 68,914 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-09-08 | 5,000 | $1.72 | 73,914 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. Shares were acquired in multiple transactions on August 31, 2015 at prices ranging from $1.62 per share to $1.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- Represents the weighted average purchase price. Shares were acquired in multiple transactions on September 1, 2015 at prices ranging from $1.72 per share to $1.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- Represents the weighted average purchase price. Shares were acquired in multiple transactions on September 3, 2015 at prices ranging from $1.68 per share to $1.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- Represents the weighted average purchase price. Shares were acquired in multiple transactions on September 4, 2015 at prices ranging from $1.73 per share to $1.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- Represents the weighted average purchase price. Shares were acquired in multiple transactions on September 8, 2015 at prices ranging from $1.70 per share to $1.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.